Delivery Order SPE2DR25D3301-SPE2DR26F18QB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Eletriptan HBr 20 mg tablets in unit dose packages of six, with a contract value of $6,194.88. The award, issued on September 29, 2025, is a firm fixed price delivery order with no set-aside designation, indicating competitive award status. Performance will take place at the contractor's Conshohocken, Pennsylvania location, with an ultimate completion date of September 30, 2025. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Eletriptan HBr 40 mg tablet unit dose packages (6-count), with a ceiling value of $1,119.38. This is a firm fixed price delivery order with no set-aside designation, issued competitively under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $8,573.76 to AmerisourceBergen Drug Corp for the supply of Eletriptan HBr 40 mg tablets in unit-dose packages of six. The contract, awarded on November 25, 2025, with an ultimate completion date of November 26, 2025, employs firm fixed pricing with no set-aside designation, indicating competitive award. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,519.96 to AmerisourceBergen Drug Corp for Eletriptan HBr 40 mg tablets in unit-dose packaging (6-count) on November 3, 2025, with an ultimate completion date of November 4, 2025. This is a firm fixed-price, non-set-aside delivery order executed under a larger contract vehicle. The product will be delivered to AmerisourceBergen's headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $3,113.79 delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Eletriptan HBr 20 mg tablets in unit dose packages of six. The contract is firm fixed price with an ultimate completion date of October 17, 2025, and represents a non-set-aside competitive award. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Eletriptan HBR 40 mg tablets in unit dose packaging (6 tablets per package). This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,173.45 and is scheduled for ultimate completion on November 4, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,815.17 on August 27, 2025, for the supply of Eletriptan HBr 40 mg tablets in unit dose packages of six. This is a firm fixed price, non-set-aside contract with performance in Conshohocken, Pennsylvania, and an ultimate completion date of August 28, 2025. Eletriptan is a triptan-class medication used to treat acute migraine headaches, representing part of the agency's pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Eletriptan HBr 40 mg tablets in unit dose packages of six, with a ceiling value of $1,390.26 and a firm fixed price structure. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $8,218.11 to AmerisourceBergen Drug Corp for the supply of Eletriptan HBR 40 mg tablets in unit dose packaging (6 tablets per package). This competitive award, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, utilizes firm fixed pricing under a delivery order contract type. The pharmaceutical product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency (DLA) has awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product Eletriptan HBR 40 mg Tablet UD 6s. The contract, valued at $1,273.33, has a firm fixed price and an ultimate completion date of April 19, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F18QBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Eletriptan HBR 40 mg tablets in unit dose packaging on November 25, 2025. This competitively awarded, firm fixed-price contract has a ceiling value of $1,747.36 and is scheduled for completion by November 26, 2025. The award represents a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement designated SPE2DX and running through December 2026. Performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement needs supporting military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains through open competition. Eletriptan, a triptan-class medication used for migraine treatment, represents one of numerous pharmaceutical products the contractor delivers through its DLA relationships to support Defense Health Agency operations and other federal healthcare systems globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 11/24/25 |